APA (7th ed.) Citation

Ye, D., Li, H., Wang, Y., Jia, W., Zhou, J., Fan, J., . . . Xu, A. (2016). Circulating Fibroblast Growth Factor 21 Is A Sensitive Biomarker for Severe Ischemia/reperfusion Injury in Patients with Liver Transplantation. Scientific reports, 6(1), 19776. https://doi.org/10.1038/srep19776

Chicago Style (17th ed.) Citation

Ye, Dewei, et al. "Circulating Fibroblast Growth Factor 21 Is A Sensitive Biomarker for Severe Ischemia/reperfusion Injury in Patients with Liver Transplantation." Scientific Reports 6, no. 1 (2016): 19776. https://doi.org/10.1038/srep19776.

MLA (9th ed.) Citation

Ye, Dewei, et al. "Circulating Fibroblast Growth Factor 21 Is A Sensitive Biomarker for Severe Ischemia/reperfusion Injury in Patients with Liver Transplantation." Scientific Reports, vol. 6, no. 1, 2016, p. 19776, https://doi.org/10.1038/srep19776.